Fukuyama City Hospital

Recent papers from Fukuyama City Hospital

1. Vascular Access Construction Using a Saphenous Vein Graft between the Subcutaneously Fixed Superficial Brachial Artery and Satellite Vein in a Young Patient Undergoing Hemodialysis with Inaccessible Superficial Veins for Arteriovenous Shunt FormationThe Journal of Japanese College of Angiology · 2026
2. Which CRT candidates may benefit from index-procedure LV lead availability during attempted LBBAP? Insights from an attempted LOT-CRT cohortEuropean Heart Journal · 2026
3. Prognostic Significance and Clinical Robustness of the HALP Score in Super‐Elderly Patients Undergoing Curative Gastrectomy for Gastric Cancer: A Multicenter Retrospective Cohort StudyAnnals of Gastroenterological Surgery · 2026
4. Intravenous leiomyomatosis with marked edematous degeneration mimicking IVC thrombus: A case reportRadiology Case Reports · 2026
5. Long-Lasting Mental Disorders in Caregivers of ICU Sepsis Survivors and Their Association With Patients’ Post-Intensive Care Syndrome: A Prospective Multicenter Cohort StudyCritical Care Medicine · 2026
6. Heart Failure Predicts Contralateral Limb Progression After Endovascular Therapy for Initial Unilateral Chronic Limb-Threatening IschemiaJournal of Endovascular Therapy · 2026
7. Efficacy of the Peritoneovenous Shunt as Palliative Care for Patients with Advanced Cancer with Refractory Ascites: A Randomized Controlled Trial (JIVROSG-0803 Study)Interventional Radiology · 2026
8. Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus TremelimumabJournal of Gastroenterology and Hepatology · 2026
9. The Geriatric Nutritional Risk Index Predicts Short‐ and Long‐Term Outcomes in the Oldest‐Old With Colorectal Cancer: A Multi‐Institutional Analysis of 225 NonagenariansAnnals of Gastroenterological Surgery · 2026
10. Association Between Acute-Phase Occupational Therapy and Quality of Life at Hospital Discharge and 90 Days After DischargeJournal of Clinical Medicine · 2026
11. CHA2DS2-VASc Score for Risk Stratification After Endovascular Therapy in Patients With Symptomatic Peripheral Artery DiseaseJournal of Endovascular Therapy · 2026
12. Successful treatment using pemigatinib in a myeloid/lymphoid neoplasm with eosinophilia with FGFR1 rearrangement and rare chromosomal abnormalitiesLeukemia & lymphoma/Leukemia and lymphoma · 2026
13. Impact of atrial fibrillation on heart failure-related events after endovascular therapy for peripheral artery diseaseHeart and Vessels · 2026
14. The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology ReviewJournal of Hepato-Biliary-Pancreatic Sciences · 2026
15. Persistent inflammation, immunosuppression and catabolism syndrome and malnutrition in critically ill patients with sepsis: A multi-center prospective observational studyClinical Nutrition · 2026
16. Prognostic impact of heart failure phenotype on survival after endovascular therapy for peripheral artery disease: Insights from the multicenter retrospective SETers studyJVS-Vascular Insights · 2026
17. Atezolizumab–Bevacizumab with or without Cisplatin-based HAIC for Unresectable HCC: A Randomized Phase 2 TrialJHEP Reports · 2026
18. Bidirectional changes in recorded pediatric asthma diagnoses with respiratory virus activity: A nationwide interrupted time-series analysis in JapanAllergology International · 2026
19. Eribulin versus taxane as first-line chemotherapy combined with dual HER2 blockade in patients with HER2-positive locally advanced or metastatic breast cancer: final survival outcomes of the JBCRG-M06/EMERALD studyESMO Open · 2026
20. Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trialJournal of Diabetes Investigation · 2026